Angitia Biopharmaceuticals
Latest round
- Series D
Last raised
- Feb 2026
Total raised
- $406M
Investors
- 26
About Angitia Biopharmaceuticals
Founded in 2018 and based in California, US, Angitia Biopharmaceuticals Limited operates as a biotechnology company that develops therapies for musculoskeletal diseases. Established in 2018 and based in Guangzhou, China, Angitia Biopharmaceuticals Guangzhou Limited is a biotechnology company that focuses on the research and development of therapeutics for musculoskeletal diseases. The founder and CEO Prof., and has more than 30 years of experience in R&D management and industrialization of bone disease drugs. In 2019, a bone and joint new drug development platform was released. The company focuses on the research and development of new drugs for bone, joint, and muscle diseases including spinal degenerative diseases, osteoporosis, osteogenesis imperfecta, tumor bone metastasis, etc. The pipeline of drugs under development includes AGA111 and AGA2118, etc.
Who invested in Angitia Biopharmaceuticals
26 investors across 7 rounds
See all investors in Angitia Biopharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Feb 5, 2026
Amount
$130M
Investors
Series C
Dec 11, 2024
Amount
$120M
Investors
Series B
Jan 1, 2024
Amount
$40M
Investors
Series B
Oct 19, 2023
Amount
$46M
Investors
Series B
Oct 31, 2021
Amount
$70M
Investors
Series A
Aug 19, 2020
Amount
Undisclosed
Investors
Angel
Mar 21, 2019
Amount
Undisclosed
Investors
Questions about Angitia Biopharmaceuticals
Who invested in Angitia Biopharmaceuticals?
Angitia Biopharmaceuticals has 26 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Angitia Biopharmaceuticals raised?
Angitia Biopharmaceuticals has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did Angitia Biopharmaceuticals last raise money?
Angitia Biopharmaceuticals's most recent round on record is a Series D, in Feb 2026.
What does Angitia Biopharmaceuticals do?
Founded in 2018 and based in California, US, Angitia Biopharmaceuticals Limited operates as a biotechnology company that develops therapies for musculoskeletal diseases.
Where is Angitia Biopharmaceuticals headquartered?
Angitia Biopharmaceuticals is headquartered in Westlake Village, US.
Which VCs invest in companies like Angitia Biopharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Angitia Biopharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Angitia Biopharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.